State Street Corporation 13D and 13G filings for Sangamo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 12:18 pm Sale | 2023-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO | STATE STREET CORP STT | 2,708,368 1.530% | -7,080,516 (-72.33%) | Filing |
| 2023-02-07 1:49 pm Purchase | 2022-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO | STATE STREET CORP STT | 9,788,884 5.970% | 4,974,258 (+103.32%) | Filing |